Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Neovascular Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06184360
What this trial is testing

Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 2,079
Not applicableWithdrawnNCT02457026
What this trial is testing

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Duke University
Not applicableUnknownNCT03944070
What this trial is testing

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Who this might be right for
Wet Macular DegenerationCataract Extraction
Ophthalmica Eye Institute 16
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Post-approval studies (Phase 4)Study completedNCT02944227
What this trial is testing

Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Seoul National University Hospital 20
Not applicableLooking for participantsNCT02669953
What this trial is testing

Aflibercept in Recurrent or Persistent CNV

Who this might be right for
Age Related Macular DegenerationIntravitreal InjectionsDiabetic Macular Edema
Medical University of Vienna 80
Not applicableUnknownNCT04268836
What this trial is testing

Vision Improvement for Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Optimal Acuity Corporation 200
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Post-approval studies (Phase 4)Study completedNCT01722045
What this trial is testing

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

Who this might be right for
Age - Related Macular Degeneration (AMD)
Regeneron Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT06664502
What this trial is testing

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (NVAMD)BRVO - Branch Retinal Vein Occlusion
EyeBiotech Ltd. 38
Large-scale testing (Phase 3)Study completedNCT03034772
What this trial is testing

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
Wills Eye 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557121
What this trial is testing

Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
AiViva BioPharma, Inc. 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05461339
What this trial is testing

TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
BioDlink Biopharm Co., Ltd. 488
Not applicableStudy completedNCT05082415
What this trial is testing

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,456
Early research (Phase 1)Not Yet RecruitingNCT07817615
What this trial is testing

A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)Retinal Vein Occlusion (RVO)
Changchun GeneScience Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT04626128
What this trial is testing

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 27
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Not applicableNot Yet RecruitingNCT07826286
What this trial is testing

Changes in Intraocular Pressure After Intravitreal Injection

Who this might be right for
Diabetic Macular EdemaNeovascular Age-Related Macular DegenerationRetinal Vein Occlusion+1 more
Assiut University 50
Not applicableStudy completedNCT03714308
What this trial is testing

Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina.

Who this might be right for
Macular Degeneration
Bayer 554
Next Page